AMAL Therapeutics (AMAL) is a pre-clinical stage Swiss biotech, developing unique therapeutic vaccines.
Our aim is to overcome the challenges around effective anti-cancer therapy by stimulating a patient’s immune system in a unique way, in order to create immunological memory, as well as target a broad range of patients. Our headquarters and laboratory facilities are located on the campus of the University of Geneva providi...
AMAL Therapeutics (AMAL) is a pre-clinical stage Swiss biotech, developing unique therapeutic vaccines.
Our aim is to overcome the challenges around effective anti-cancer therapy by stimulating a patient’s immune system in a unique way, in order to create immunological memory, as well as target a broad range of patients. Our headquarters and laboratory facilities are located on the campus of the University of Geneva providing access to state of the art platforms and know-how. ATP128, our lead program in metastatic colorectal cancer is expected to enter the clinic in 2019.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.